使用种系 BRCA 检测对患有卵巢癌和商业保险的患者进行检测。
Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance.
机构信息
Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Brigham and Women's Hospital, Boston, Massachusetts.
Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
出版信息
JAMA Netw Open. 2022 Jan 4;5(1):e2142703. doi: 10.1001/jamanetworkopen.2021.42703.
Abstract
This cross-sectional study evaluates changes in the rate of germline BRCA testing among patients with ovarian cancer between 2008 and 2018 and analyzes factors associated with testing rates.
摘要
本横断面研究评估了 2008 年至 2018 年间卵巢癌患者中胚系 BRCA 检测率的变化，并分析了与检测率相关的因素。
Zotero 插件